Comparision of glargine insulin and Regular insulin on quality of perioperative glucose control
Phase 3
- Conditions
- Type 2 diabetes mellitus.Type 2 diabetes mellitus
- Registration Number
- IRCT20141127020112N8
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Age: 30-70 years old
Duration of diabetes for more than three months
New York Heart Association (NYHA) class 1 or 2
Exclusion Criteria
Diabetic ketoacidosis or its history
Renal failure
Liver failure
Hypoglycemia episodes in a hospital
Hyperglycemia without a history of diabetes
Pregnancy
Patients or psychiatric disorders that can not provide information
Corticosteroid use
Infection and sepsis
BMI more than 35
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood Glucose. Timepoint: Every 45 minutes during surgery. Method of measurement: Glucometry.
- Secondary Outcome Measures
Name Time Method Blood potassium. Timepoint: 2 and 4 hours after surgery. Method of measurement: Blood test.